pharmanewsblog.blogspot.com
Pharma News Blog: February 2013
http://pharmanewsblog.blogspot.com/2013_02_01_archive.html
Thursday, February 7, 2013. Drug agency Recommends Lower Dose of Ambien for Women. Ambien was taken for sleep in American’s for almost 20 years. However, FDA- food and drug administration got complaints that taking that drug made them drowsy the next morning and sometimes led to accidents. After test on drowsiness risk on driving, the agency said on Thursday that woman should take half the drug. There were many reports in regards to problems caused after the use of sleeping pills, and doctors have questi...
pharmanewsblog.blogspot.com
Pharma News Blog: January 2013
http://pharmanewsblog.blogspot.com/2013_01_01_archive.html
Wednesday, January 30, 2013. Tasimelteon, Sleep Disorder Drug, Shows Promising Result. Tasimelteon was able to pass the second trial which was late stage and the results were good. It is effective against a rare condition called NON-24: Non 24 hours sleep wake disorder. NON -24 is a sleep cicadian rhythm disorder. Vanda’s drug helps to regulate circadian rhythm and act as melatonin agonist. To check the safety and efficiency of the drug a study was conducted where people were treated. As said by Steven W...
pharmanewsblog.blogspot.com
Pharma News Blog: Avastin, a drug for Breast Cancer Patients Found Useful but Restricted
http://pharmanewsblog.blogspot.com/2013/01/avastin-drug-for-breast-cancer-patients.html
Wednesday, January 9, 2013. Avastin, a drug for Breast Cancer Patients Found Useful but Restricted. Efficacy of a new drug named Avastin to treat tumors from those suffering from breast cancer at their early stages may get revisited. Avastin is found useful in treating breast cancer. Were safe than those with only chemo alone. Regular precautions and research are being made as it not stated that Avastin can continue existence. The drug can also cause harm, said experts. The California-based Genentech, th...
pharmanewsblog.blogspot.com
Pharma News Blog: December 2011
http://pharmanewsblog.blogspot.com/2011_12_01_archive.html
Monday, December 26, 2011. Berlin heart pump for weak hearted kids gets FDA nod. It happens more that doctors are unable to find a donor for children suffering from heart ailments and it is tough to pull on in the same manner. However, the million dollar question is it possible that the patients may survive until they get a life saver? The device is usage for all the children falling in various age groups from the newborns to the teenagers. Posted by Health Admin. Subscribe to: Posts (Atom).
pharmanewsblog.blogspot.com
Pharma News Blog: Does Alternative Medicines Really Work?
http://pharmanewsblog.blogspot.com/2013/02/does-alternative-medicines-really-work.html
Friday, February 1, 2013. Does Alternative Medicines Really Work? Views are little ambivalent when it comes to alternative medicines. Reason for that is alternative medicine is very broad spectrum. Because of half a dozen varieties it is difficult to understand what really defines alternative medicine. One would definitely have got question in their mind on why do alternative medicines work? What is the reason of the success where as it does not have scientifically proven method? People who oppose altern...
pharmanewsblog.blogspot.com
Pharma News Blog: Tasimelteon, Sleep Disorder Drug, Shows Promising Result
http://pharmanewsblog.blogspot.com/2013/01/tasimelteon-sleep-disorder-drug-shows.html
Wednesday, January 30, 2013. Tasimelteon, Sleep Disorder Drug, Shows Promising Result. Tasimelteon was able to pass the second trial which was late stage and the results were good. It is effective against a rare condition called NON-24: Non 24 hours sleep wake disorder. NON -24 is a sleep cicadian rhythm disorder. Vanda’s drug helps to regulate circadian rhythm and act as melatonin agonist. To check the safety and efficiency of the drug a study was conducted where people were treated. As said by Steven W...
pharmanewsblog.blogspot.com
Pharma News Blog: April 2012
http://pharmanewsblog.blogspot.com/2012_04_01_archive.html
Friday, April 27, 2012. Glaucoma Treatment, Frost Predicts Huge Mart. Glaucoma is one of top causes for blindness across the world. In USA alone it is second top complication which leads to blindness. Frost and Sullivan, a market research company sees significant opportunities in pharmaceutical market of glaucoma treatment. Since glaucoma is widely occurs in old people, likelihood of market expansion is greater as patients grow old. There are couple of drug treatment for glaucoma in market such as prosta...
pharmanewsblog.blogspot.com
Pharma News Blog: November 2012
http://pharmanewsblog.blogspot.com/2012_11_01_archive.html
Tuesday, November 6, 2012. FDA to take final call on smokeless tobacco products. Dissolvable Tobacco products are restricted for kids below 18 years. Tobacco products may have smell like candy bar but they are not for kids, the United States Food and Drug Department highlighted in a conference this week. The smokeless tobacco dissolvable products are second very popular cause of nicotine toxin substance in broods. A study showed in Journal Pediatrics, April 2010. Winickoff also said that if youth is prev...
pharmanewsblog.blogspot.com
Pharma News Blog: March 2012
http://pharmanewsblog.blogspot.com/2012_03_01_archive.html
Thursday, March 29, 2012. Counseling Needed for Women on Fertility After Cancer Treatment Chemotherapy. Found that not all young women, who receive cancer treatment, taking precocious measures to preserve fertility. Study found very few women take counseling on presevin fertility after cancer treatment. Different perceptions were seen in different groups of young women. Some women take measures such as eggs freezing or preserving embryo, says Dr Mitchell Rosen. Cancer suffering women of age between 18 to...